Publications by authors named "Gunter Emons"

Claim this Profile
E
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022) - Part 2 with Recommendations on the Therapy of Precancerous Lesions and Early-stage Endometrial Cancer, Surgical Therapy, Radiotherapy and Drug-based Therapy, Follow-up Care, Recurrence and Metastases, Psycho-oncological Care, Palliative Care, Patient Education, and Rehabilitative and Physiotherapeutic Care.
Günter Emons, Eric Steiner, Dirk Vordermark, Christoph Uleer, Kerstin Paradies

Geburtshilfe Frauenheilkd· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures.
Günter Emons, Eric Steiner, Dirk Vordermark, Christoph Uleer, Kerstin Paradies

Geburtshilfe Frauenheilkd· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial.
Jacobus Pfisterer, Florence Joly, Gunnar Kristensen, Joern Rau, Sven Mahner, Günter Emons

J Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hormone-Dependent Cancers: Molecular Mechanisms and Therapeutical Implications.
Günter Emons

Cells· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors.
Rita K Schmutzler, Björn Schmitz-Luhn, Bettina Borisch, Peter Devilee, Diana Eccles, Günter Emons

Breast Care (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6).
Günter Emons, Jae-Weon Kim, Karin Weide, Nikolaus de Gregorio, Pauline Wimberger

Int J Gynecol Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perimenopause and Postmenopause - Diagnosis and Interventions. Guideline of the DGGG and OEGGG (S3-Level, AWMF Registry Number 015-062, September 2020).
Elisabeth C Inwald, Christian Albring, Erika Baum, Maria Beckermann, Kai J Bühling, Günter Emons

Geburtshilfe Frauenheilkd· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Gonadotropin-Releasing Hormone (GnRH) in Endometrial Cancer.
Günter Emons, Carsten Gründker

Cells· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer.
Carsten Gründker, Günter Emons

Cells· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of rectal/bladder filling and applicator positioning on in vivo rectal dosimetry in vaginal cuff brachytherapy using an enhanced therapy setting.
Pia Franziska Luise Bergau, Markus A Schirmer, Andreas Leha, Martin Leu, Günter Emons

Brachytherapy· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of ARHGAP29 on the Invasion of Mesenchymal-Transformed Breast Cancer Cells.
Katharina Kolb, Johanna Hellinger, Maike Kansy, Florian Wegwitz, Gerd Bauerschmitz, Günter Emons

Cells· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of drivers of breast cancer invasion by secretome analysis: insight into CTGF signaling.
Johanna W Hellinger, Franziska Schömel, Judith V Buse, Christof Lenz, Gerd Bauerschmitz, Günter Emons

Sci Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive pelvic and paraaortic lymphadenectomy in patients with apparently early stage uterine serous carcinoma - an anachronism?
Günter Emons

J Gynecol Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tamoxifen and Endometrial Cancer: A Janus-Headed Drug.
Günter Emons, Alexander Mustea, Clemens Tempfer

Cancers (Basel)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shedding New Light on Cancer Metabolism: A Metabolic Tightrope Between Life and Death.
Matthias Läsche, Günter Emons, Carsten Gründker

Front Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Radiotherapy and/or Chemotherapy for Endometrial Cancer, Status as at 2019: Opinion of the Uterus Commission of the Gynecological Oncology Working Group (AGO).
Günter Emons, Clemens Tempfer, Marco Johannes Battista, Alexander Mustea, Dirk Vordermark

Geburtshilfe Frauenheilkd· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of CYR61-S100A4 Axis Limits Breast Cancer Invasion.
Johanna W Hellinger, Silke Hüchel, Lena Goetz, Gerd Bauerschmitz, Günter Emons

Front Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant treatment for endometrial cancer.
Günter Emons, Dirk Vordermark

Curr Opin Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of aerobic glycolysis enhances the anti-tumor efficacy of Zoptarelin Doxorubicin in triple-negative breast cancer cells.
Carsten Gründker, Ulrike Wokoun, Martin Hellriegel, Günter Emons

J Obstet Gynaecol Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of Metastasis and Cell Mobility - The Role of Metabolism.
Carsten Gründker, Matthias Läsche, Johanna W Hellinger, Günter Emons

Geburtshilfe Frauenheilkd· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the evidence for lymphadenectomy in presumed early ovarian cancer?
Barbara Schmalfeldt, Christine Brambs, Alexander Burges, Ahmed El-Balat, Günter Emons

Arch Gynecol Obstet· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER.
Rainer Girgert, Günter Emons, Carsten Gründker

Front Endocrinol (Lausanne)· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities.
Günter Emons, Eric Steiner, Dirk Vordermark, Christoph Uleer, Nina Bock

Geburtshilfe Frauenheilkd· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer.
Günter Emons, Eric Steiner, Dirk Vordermark, Christoph Uleer, Nina Bock

Geburtshilfe Frauenheilkd· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of growth hormone receptor by Somavert reduces expression of GPER and prevents growth stimulation of triple-negative breast cancer by 17β-estradiol.
Rainer Girgert, Günter Emons, Carsten Gründker

Oncol Lett· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis